- About Senior Care Pharmacy
- Who We Are
|The Consultant Pharmacist|
IN THIS ISSUE
September 2017 | Volume 32 | Number 9
Students' Perspectives on Nebulized Drugs and Nebulizer Maintenance
Potentially Inappropriate Medication Prescribing in U.S. Older Adults:
Decisions that providers make regarding pharmacotherapy choices for older adults are often challenging.
The geriatric population requires specific considerations in using inhalation therapy, and it is recommended that the majority of geriatric patients receive respiratory therapies via a nebulizer device. If nebulizers cannot be used to deliver particular medications, then dry powdered inhalers and soft-mist inhalers are recommended over metered dose inhalers for this population.
The evidence to support a specific time frame for discontinuation of Alzheimer’s disease treatment is minimal. It is reasonable to stop a medication if there is no noticeable benefit after the first three months of treatment or once a patient’s dementia progresses to a point where there would be no meaningful benefit from continued therapy.
Potentially Inappropriate Medication Prescribing in U.S. Older Adults with Selected Chronic Conditions
Developing one or more chronic diseases increases with age. Appropriate treatment for chronic conditions often require multiple medications. The purpose of this study was to examine potentially inappropriate prescriptions in patients 65 years of age or older, seen in a primary care office, with at least one of three chronic conditions (diabetes, arthritis, depression), who were prescribed at least two medications, one of which was inappropriate for the patient’s condition.
The data collected in this study imply that an absence of tamoxifen pharmacovigilance documentation is the normal standard of care. Therefore, there were many missed opportunities to provide improved patient care. Because of minimal pharmacovigilance of tamoxifen therapy, patients can be at an increased risk for developing serious complications such as thromboembolic events and uterine abnormalities.
Elias B. Chahine, PharmD, FCCP, BCPS (AQ-ID), is an associate professor of pharmacy practice at Palm Beach Atlantic University’s Lloyd L. Gregory School of Pharmacy, West Palm Beach, and a clinical pharmacy specialist at Wellington Regional Medical Center, Wellington, Florida.
Pharmacists recently gathered at a conference outside of Washington, D.C., to survey the landscape of legislative, regulatory, and technology-related issues that will impact their work now and in the future. Participants also discussed how to establish an electronic health record information exchange.
Cutting-edge technology that enables effective communication between settings and provides all practitioners with the information they need—when they need it—remains elusive in post-acute and long-term care.
Neither party has either the will or the policy solutions to do what the public professes to want most: a health care system that consumes less than 20% of the nation’s annual economic output.
As consultant pharmacists know, vaccines help prevent diseases that disproportionately affect the elderly population. Vaccines not only help block conditions such as influenza, pneumonia, herpes zoster, and pertussis, but they also help save the billions of dollars these diseases cost.
READ THE JOURNAL
The Consultant Pharmacist® is the official monthly peer-reviewed journal of the American Society of Consultant Pharmacists (ASCP). It is the only journal dedicated exclusively to the medication therapy needs of seniors. ASCP members receive The Consultant Pharmacist® as a member benefit. All articles (2004 to present) are free online for members.
2017 ASCP Integrated Media Kit
Nonmembers can access online abstracts to journal articles. Full articles are available for $35.00 each.
Content can be tailored and customized to fit your marketing and promotional needs and can be delivered via print or electronic format. For more information, contact: